Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene

DSpace/Manakin Repository

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene

Citable link to this page

 

 
Title: Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
Author: Miller, Shyra J; Jessen, Walter J; Mehta, Tapan; Hardiman, Atira; Sites, Emily; Kaiser, Sergio; Jegga, Anil G; Upadhyaya, Meena; Giovannini, Marco; Wallace, Margaret R; Lopez, Eva; Serra, Eduard; Lazaro, Conxi; Page, Grier; Aronow, Bruce J; Ratner, Nancy; Li, Hua; Muir, David; Nielsen, Gunnlaugur Petur; Stemmer-Rachamimov, Anat

Note: Order does not necessarily reflect citation order of authors.

Citation: Miller, Shyra J, Walter J Jessen, Tapan Mehta, Atira Hardiman, Emily Sites, Sergio Kaiser, Anil G Jegga, et al. 2009. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Molecular Medicine 1(4): 236-248.
Full Text & Related Files:
Abstract: Understanding the biological pathways critical for common neurofibromatosis type 1 (NF1) peripheral nerve tumours is essential, as there is a lack of tumour biomarkers, prognostic factors and therapeutics. We used gene expression profiling to define transcriptional changes between primary normal Schwann cells (n = 10), NF1-derived primary benign neurofibroma Schwann cells (NFSCs) (n = 22), malignant peripheral nerve sheath tumour (MPNST) cell lines (n = 13), benign neurofibromas (NF) (n = 26) and MPNST (n = 6). Dermal and plexiform NFs were indistinguishable. A prominent theme in the analysis was aberrant differentiation. NFs repressed gene programs normally active in Schwann cell precursors and immature Schwann cells. MPNST signatures strongly differed; genes up-regulated in sarcomas were significantly enriched for genes activated in neural crest cells. We validated the differential expression of 82 genes including the neural crest transcription factor SOX9 and SOX9 predicted targets. SOX9 immunoreactivity was robust in NF and MPSNT tissue sections and targeting SOX9 – strongly expressed in NF1-related tumours – caused MPNST cell death. SOX9 is a biomarker of NF and MPNST, and possibly a therapeutic target in NF1.
Published Version: doi:10.1002/emmm.200900027
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378132/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10482561
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters